年迈体弱和重症肿瘤患者免疫力极低,通常都无法承受手术等创伤性和对抗性的治疗。既然疾病不能去本,那我们何不以患者身体健康为出发点,来个带瘤生存呢?通过有效手段控制、严防病灶发展是带瘤生存的关键。有研究发现,部分中晚期肿瘤患者在服用灵芝三萜类生物制剂 Older frail and critically ill patients have very low immunity and often can not tolerate traumatic and confrontational therapies such as surgery. Since the disease can not go to this, then why do not we take the patient’s health as the starting point, to bring a tumor to survive it? By effective means of control, prevent the development of lesions is the key to tumor survival. Some studies have found that some of the advanced cancer patients taking Ganoderma lucidum triterpene biological agents